Nektar Therapeutics to Participate in Fireside Chat at the Goldman Sachs 44th Annual Global Healthcare Conference Nektar Therapeutics' (Nasdaq: NKTR) senior management is scheduled to participate in a virtual fireside chat at the upcoming Goldman Sachs 44th...
Monday, June 12, 2023 1 min read
Key Takeaway: Nektar Therapeutics will participate in a virtual fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on June 14, 2023. Senior management from Nektar is scheduled to present at 1:20 p.m. Pacific Time, with the presentation available via webcast. The event will showcase Nektar's investigational medicines in immunology and oncology, emphasizing the company's strong R&D pipeline.
Market Sentiment Analysis
POSITIVE FACTORS
Participation in a high-profile healthcare conference.
Opportunity to showcase Nektar's robust R&D pipeline.
Visibility for company leadership during the fireside chat.
Full Press Release Details
SAN FRANCISCO , June 12, 2023 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR ) senior management is scheduled to participate in a virtual fireside chat at the upcoming Goldman Sachs 44 th Annual Global Healthcare Conference on Wednesday, June 14, 2023 at 1:20 p.m. Pacific Time .
The presentation will be accessible via a webcast through a link posted on the Investor Events section of the Nektar website: http://ir.nektar.com/events-and-presentations/events . This Webcast will be available for replay until July 14, 2023 .
About Nektar Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in immunology and oncology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California , with additional manufacturing operations in Huntsville, Alabama . Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com .
For Investors: Vivian Wu of Nektar Therapeutics 628-895-0661
For Media: David Rosen of Argot Partners (212) 600-1902 [email protected]
SOURCE Nektar Therapeutics
21 %
Frequently Asked Questions
When is Nektar Therapeutics' fireside chat scheduled?
The fireside chat is scheduled for June 14, 2023, at 1:20 p.m. PT.
How can I access the Nektar Therapeutics webcast?
The webcast can be accessed via the Investor Events section on Nektar's website.
What is the duration for the replay of the webcast?
The webcast will be available for replay until July 14, 2023.
Where is Nektar Therapeutics headquartered?
Nektar Therapeutics is headquartered in San Francisco, California.
What focus areas does Nektar Therapeutics specialize in?
Nektar specializes in immunology and oncology with a strong R&D pipeline.